{"schema_version":"secwatch.filing_event.v1","accession":"0000200406-25-000110","form_type":"8-K","ticker":"JNJ","cik":"0000200406","company_name":"JOHNSON & JOHNSON","filed_at":"2025-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.669779+00:00","generated_at":"2026-05-23T15:05:21.885640+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"JNJ Q1 adj EPS $2.77 (+2.2%), revenue $21.9B; dividend +4.8% to $1.30","bullets":["GAAP net earnings $11.0B ($4.54 diluted EPS) vs $3.3B ($1.34), boosted by $7.3B other income.","Adjusted net earnings $6.71B ($2.77 diluted EPS) vs $6.58B ($2.71), up 1.9% operationally.","Worldwide sales $21.89B, up 2.4% reported, 4.2% operational; US +5.9%, International -1.8%.","Innovative Medicine $13.87B (+2.3% reported, +4.2% op); MedTech $8.02B (+2.5% reported, +4.1% op).","Dividend raised 4.8% to $1.30/quarter, payable June 10, 2025; record May 27, 2025; 63rd annual increase."],"urls":{"canonical":"https://secwatch.observer/filing/0000200406-25-000110","json":"https://secwatch.observer/filing/0000200406-25-000110.json","markdown":"https://secwatch.observer/filing/0000200406-25-000110.md","text":"https://secwatch.observer/filing/0000200406-25-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/0000200406-25-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/jnj-20250415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:05:21.885640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}